James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains Analysis of HPV-Positive Malignancies | TGF-? Dysregulation is Seen in…
Browsing: Hematologic Malignancies
Ana Limon Carrera, Takeda Oncology, shares TAK-931 – A CDC7 Inhibitor in Solid Tumors | Dosage Collision Study Shows Treatment…
James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains M7824 – Novel Bifunctional Protein | Anti-Body Targeting PD-L1, Sequester…
Patients suffering from acute myeloid leukemia (AML) who have achieved complete remission are still at risk of relapse. Assessing blood…
Thrombotic microangiopathy (TMA) is a rare complication that may arise post-transplant in patients, however, incidence of TMA has increased in…
The complications in blood and marrow transplantation can be serious with rapid onset, therefore ideal donor matching is crucial in…
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Mohamad Mohty, MD,…
There has been an increase in the number of patients with refractory hematological malignancies being referred to transplant centers, although…
The therapeutic landscape of Hodgkin lymphoma has improved considerably over the past 50 years, with patient outcomes improving due to…
Disease relapse is a significant cause of transplant failure in patients with acute myeloid leukemia (AML). Talking at the 2018…
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, from University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, outlines the breakthrough therapies…
Cure Leukemia is a leading center for the development of new drug and transplant treatments for patients with hematological cancers.…
There is a desperate need for rapid turnaround of transplant clinical trials to bring forward breakthrough therapies. IMPACT is a…
Ruben Niesvizky, MD, explains Incorporating Different Schedules into Combinations Use minimum active dose at Imedex Great Debates 2018.
Ruben Niesvizky, MD, explains Quadruple Agents in Relapse Refractory Myeloma Capitalizing on synergy & lack of toxicities at Imedex Great…
Paul G. Richardson, MD, explains Adding to Lenalidomide to Make it Work Better Prednisone inhibitors, carfilzomib, and bortezomib at Imedex…
Paul G. Richardson, MD, explains One Size Does Not Fit All in Myeloma Clonal Tiding & Complex Heterogeneity at Imedex…
Paul G. Richardson, MD, explains Early Transplant Confers PFS Benefit, but Not Overall Stem cell transplant is an option at…
Paul G. Richardson, MD, explains Combinations with RVD Beyond Daratumumab Data with ixazomib, revlimid, & dexamethasone at Imedex Great Debates…
Paul G. Richardson, MD, explains RVD-Lite Mission Treating Over 50 Patients Regimen of Bortezomib, lenalidomide, steroids at Imedex Great Debates…
Hyperhydration is typically used along with high-dose melphalan in patients undergoing stem cell transplantation. However, the evidence behind this practice…
The European Society for Blood and Marrow Transplantation (EBMT) have recently set up their dedicated EBMT Patient Advisory and Advocacy…
Blood and bone marrow transplantation continues to experience breakthroughs, with the role of the patient becoming increasingly important. In this…
The Worldwide Network for Blood & Marrow Transplantation (WBMT) is an umbrella organization for institutions and centers carrying out blood…